GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

M201-A   Click here for help

GtoPdb Ligand ID: 13228

Compound class: Synthetic organic
Comment: M201-A is a novel ryanodine receptor 2 (RyR2) inhibitor [1]. It was principally designed for the treatment of heart failure.
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/). All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 5
Hydrogen bond donors 0
Rotatable bonds 7
Topological polar surface area 69.06
Molecular weight 440.6
XLogP 1.46
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

✖
Canonical SMILES COC1=CC=C2C(=C1)CN(CC[S@]2=O)C(=O)CCN3CCC(CC3)CC4=CC=CC=C4
Isomeric SMILES COC1=CC2=C(C=C1)[S@](=O)CCN(C2)C(=O)CCN3CCC(CC3)CC4=CC=CC=C4
InChI InChI=1S/C25H32N2O3S/c1-30-23-7-8-24-22(18-23)19-27(15-16-31(24)29)25(28)11-14-26-12-9-21(10-13-26)17-20-5-3-2-4-6-20/h2-8,18,21H,9-17,19H2,1H3/t31-/m1/s1
InChI Key QBFZESIJRBFQRK-WJOKGBTCSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
No information available.
Summary of Clinical Use Click here for help
M201-A is a clinical candidate. It is formulated as the hydrochloride salt for in vivo studies.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT04609059 First-in-Patient Study for Sing le Dose of M201-A Hydrochloride Injection in Japanese Patients With Paroxysmal Atrial Fibrillation Phase 2 Interventional Kitasato University
NCT03055403 First-in-Human Dose Escalation Study of M201-A in Healthy Japanese Subjects Phase 1 Interventional Kitasato University
NCT04464681 Multiple Dose Escalation Study of M201-A in Healthy Japanese Subjects Phase 1 Interventional Kitasato University 1